Mus vs Niger: Hepatitis B surface antigen (HBsAg) prevalence (%)
Mus
0.8%
in 2024
Niger
3.2%
in 2024
Mus rank
1st
Niger rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Mus
- Niger
How they compare
Niger currently reports 3.2% against 0.8% in Mus, a difference of 2.4%.
That makes Niger's figure about 4.0 times Mus's.
Across all 10 years both countries report, Niger has been ahead every year.
Mus ranks 1st and Niger ranks 3rd of 2 regions.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 2.6% | 1.4% | Niger |
| 2020s | 0.8% | 3.4% | 2.6% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Mus or Niger?
- Niger, at 3.2% against 0.8% in Mus as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Mus and Niger?
- 2.4%, with Niger ahead.
- How many years of comparable data are there for Mus and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Mus and Niger rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Mus ranks 1st and Niger ranks 3rd of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.